Acceptance of multiple abstracts for presentation at significant medical congresses, showcasing the company’s research on oral bradykinin B2 receptor antagonists and their relevance to treating ...

The oral presentation will feature detailed efficacy and safety results from the study of bexmarilimab in combination with standard-of-care (azacitidine) in frontline with HR-MDS and those with ...

Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy for newly diagnosed AML Oral presentation at EHA will include updated data at the 40 mg and ...

APA Corporation (NASDAQ:APA) released its first-quarter 2025 financial and operational presentation on May 7, 2025, highlighting significant cost reduction initiatives and operational efficiencies ...

The data were from the Phase 2 clinical study of high-dose IBI302 (NCT05403749) to evaluate the efficacy, safety and dosing intervals in patients with nAMD over a one-year treatment period. A ...

The oral presentation will include approaches for monitoring and managing hemophagocytic lymphohistiocytosis (HLH), a rare, severe hyperinflammatory syndrome that has been associated with systemic ...

with a six-minute oral presentation format. It aims at sharing clinical data that stood out among many submissions. The company will also present a poster on randomized Phase II data of TG4001 in ...

Marseille, France, April 23, 2025 10:00 a.m. ET / 4:00 p.m. CET- ImCheck Therapeutics announced today an oral presentation at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting ...

The meeting will take place May 14–17 in Las Vegas. The presentation will be delivered by Dr. Alessandro Villa, Chief of Oral Medicine, Oral Oncology and Dentistry, and Professor at Herbert ...

A rapid oral presentation is part of a formal session, with a six-minute oral presentation format. It aims at sharing clinical data that stood out among many submissions. The company will also ...

An Antiguan has been named among twelve oral presentation winners at the second annual One UWI Postgraduate Student Conference. Spencer, who studies at The UWI Cave Hill Campus Faculty of Science ...

today announced an oral presentation of preclinical data for ABP-102/CT-P72 at the American Association for Cancer Research Ⓡ Annual Meeting 2025 (“AACR 2025”) in the New Drugs on the ...